Reach Us +1-218-451-2974
Nasal Surgery For Rhinogenic Headache | 25673
ISSN: 2161-119X

Otolaryngology: Open Access
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences
Share This Page

Nasal surgery for rhinogenic headache

2nd International Conference and Exhibition on Rhinology and Otology

Peter Catalano

ScientificTracks Abstracts: Otolaryngol (Sunnyvale)

DOI: 10.4172/2161-119X.S1.007

The aim of this study was to evaluate the role of targeted nasal and sinus surgery in patients presenting with the primary complaint of headache, with or without sinus symptoms. The study conducted was a prospective non-controlled study. The targeted audience came from a busy metropolitan otolaryngology practice. The subjects were patients presenting with headache, with or without other rhinogenic complaints. A prospective, non-controlled study of 50 consecutive patients presented within a 12 month period for evaluation of headache as a primary symptom, with or without other rhinogenic complaints. Each patient underwent a full history, examination, pre-operative sinus CT (scored by the Lund Mackay system) and Headache Impact Test Score (HIT-6) questionnaire, followed by targeted nasal and sinus surgery. Post-operative HIT-6 was also recorded at 3 and 6 months, and the results analyzed statistically Targeted nasal and sinus surgery statistically reduced the mean HIT-6 score postoperatively, from a mean of 61.9 preoperatively to 45.5 postoperatively (p<0.05) (a HIT-6 score >60 indicates a severe impact on quality of life, while a score <49 implies a minor impact on quality of life). Patients with a lower Lund Mackay score had a larger drop in HIT-6 than those with a higher score. This study demonstrates a role for targeted and limited nasal and sinus surgery as a valid therapeutic option for patients with headache having the clinical and radiographic features described herein, and who are either not candidates for, refractory to, or not willing to use medications for control of headache symptoms.
Peter Catalano, MD is Doctor of Medicine from Mount Sinai School of Medicine in NY. He is currently Professor of Otolaryngology at the Tufts University School of Medicine, Chief of Otolaryngology at St. Elizabeth?s Medical Center. He has published over 74 publications in reputed journals; written over 21 book chapters; been invited to over 175 lectures; completed 80 presentations.